Antimicrobial activity of quinoline-based hydroxyimidazolium hybrids
dc.citation.title | Antibiotics | es |
dc.citation.volume | 8(4) | es |
dc.creator | Insuasty, Daniel | |
dc.creator | Vidal, Oscar | |
dc.creator | Bernal, Anthony | |
dc.creator | Marquez, Edgar | |
dc.creator | Guzman, Juan | |
dc.creator | Insuasty, Braulio | |
dc.creator | Svetaz, Laura Andrea | |
dc.creator | Zacchino, Susana | |
dc.creator | Puerto, Gloria | |
dc.date.accessioned | 2020-12-16T21:37:42Z | |
dc.date.available | 2020-12-16T21:37:42Z | |
dc.date.issued | 2019-11-28 | |
dc.description | Eight quinoline-based hydroxyimidazolium hybrids 7aāh were prepared and evaluated in vitro against a panel of clinically important fungal and bacterial pathogens, including mycobacteria. Hybrid compounds 7cād showed remarkable antifungal activity against Cryptococcus neoformans with a minimum inhibitory concentration (MIC) value of 15.6 Āµg/mL. Against other opportunistic fungi such as Candida spp. and Aspergillus spp., these hybrids showed MIC values of 62.5 Āµg/mL. Regarding their antibacterial activity, all the synthetic hybrids demonstrated little inhibition of Gram-negative bacteria (MIC ā„50 Āµg/mL), however, hybrid 7b displayed >50% inhibition against Klebsiella pneumoniae at 20 Āµg/mL and full inhibition at 50 Āµg/mL. Moreover, this hybrid was shown to be a potent anti-staphylococcal molecule, with a MIC value of 2 Āµg/mL (5 ĀµM). In addition, hybrid 7h also demonstrated inhibition of Staphylococcus aureus at 20 Āµg/mL (47 ĀµM). Hybrids 7a and 7b were the most potent against Mycobacterium tuberculosis H37Rv with MIC values of 20 and 10 Āµg/mL (46 and 24 ĀµM), respectively. The 7b hybrid demonstrated high selectivity in killing S. aureus and M. tuberculosis H37Rv in comparison with mammalian cells (SI >20), and thus it can be considered a hit molecule for mechanism of action studies and the exploration of related chemical space. | es |
dc.description | Para citar este articulo: Insuasty, D.; Vidal, O.; Bernal, A.; Marquez, E.; Guzman, J.; Insuasty, B.; Quiroga, J.; Svetaz, L.; Zacchino, S.; Puerto, G.; Abonia, R. Antimicrobial Activity of Quinoline-Based Hydroxyimidazolium Hybrids. Antibiotics 2019, 8, 239. | |
dc.description.fil | Fil: Insuasty, Daniel. Universidad del Norte. Departamento de QuĆmica y BiologĆa; Colombia. | es |
dc.description.fil | Fil: Vidal, Oscar. Universidad del Norte. Departamento de QuĆmica y BiologĆa; Colombia. | es |
dc.description.fil | Fil: Bernal, Anthony. Universidad del Norte. Departamento de QuĆmica y BiologĆa; Colombia. | es |
dc.description.fil | Fil: Marquez, Edgar. Universidad del Norte. Departamento de QuĆmica y BiologĆa; Colombia. | es |
dc.description.fil | Fil: Guzman, Juan. Justus Liebig University Giessen. Institute for Insect Biotechnology; Germany. | es |
dc.description.fil | Fil: Insuasty, Braulio. Universidad del Valle. Facultad de Ciencias Naturales y Exactas. Departamento de QuĆmica. Grupo de InvestigaciĆ³n de Compuestos HeterocĆclicos; Colombia. | es |
dc.description.fil | Fil: Svetaz, Laura. Universidad Nacional de Rosario. Facultad de Ciencias BioquĆmicas y FarmacĆ©uticas. Ćrea Farmacognosia; Argentina. | es |
dc.description.fil | Fil: Zacchino, Susana. Universidad Nacional de Rosario. Facultad de Ciencias BioquĆmicas y FarmacĆ©uticas. Ćrea Farmacognosia; Argentina. | es |
dc.description.fil | Fil: Puerto, Gloria. Instituto Nacional de Salud. Laboratorio de Micobacterias; Colombia. | es |
dc.description.sponsorship | Agencia Nacional de PromociĆ³n CientĆfica y TecnolĆ³gica (ANPCyT): PICT2016-1833 | es |
dc.description.sponsorship | Universidad Nacional de Rosario (UNR) | es |
dc.description.sponsorship | Departamento Administrativo de Ciencia, TecnologĆa e InnovaciĆ³n (Colciencias) | es |
dc.description.sponsorship | Universidad del Valle | es |
dc.description.sponsorship | Universidad del Norte | es |
dc.format | application/pdf | |
dc.format.extent | 1-11 | es |
dc.identifier.issn | 2079-6382 | es |
dc.identifier.uri | http://hdl.handle.net/2133/19489 | |
dc.language.iso | eng | es |
dc.publisher | MDPI | es |
dc.relation.publisherversion | https://doi.org/10.3390/antibiotics8040239 | es |
dc.relation.publisherversion | https://www.mdpi.com/2079-6382/8/4/239#cite | es |
dc.rights | openAccess | es |
dc.rights.holder | Universidad Nacional de Rosario | es |
dc.rights.holder | Insuasty, Daniel | es |
dc.rights.holder | Vidal, Oscar | es |
dc.rights.holder | Bernal, Anthony | es |
dc.rights.holder | Marquez, Edgar | es |
dc.rights.holder | Guzman, Juan | es |
dc.rights.holder | Insuasty, Braulio | es |
dc.rights.holder | Svetaz, Laura Andrea | es |
dc.rights.holder | Zacchino, Susana | es |
dc.rights.text | Attribution 4.0 International (CC BY 4.0) | es |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Quinoline-based Hydroxyimidazolium Hybrids | es |
dc.subject | Antimicrobial Activity | es |
dc.subject | Antifungal Activity | es |
dc.subject | Tuberculosis | es |
dc.subject | Cytotoxicity | es |
dc.title | Antimicrobial activity of quinoline-based hydroxyimidazolium hybrids | es |
dc.type | article | |
dc.type | artĆculo | |
dc.type | publishedVersion | |
dc.type.collection | articulo | |
dc.type.version | publishedVersion | es |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- 10 antibiotics-08-00239.pdf
- TamaƱo:
- 1.63 MB
- Formato:
- Adobe Portable Document Format
- DescripciĆ³n:
- versiĆ³n post-print
Bloque de licencias
1 - 1 de 1
- Nombre:
- license.txt
- TamaƱo:
- 3.59 KB
- Formato:
- Item-specific license agreed upon to submission
- DescripciĆ³n: